The SIRT1 inhibitor, nicotinamide, inhibits hepatitis B virus replication in vitro and in vivo

Activation of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) by Inhibitors of Class III Histone Deacetylases: Identification of Sirtuin 1 as a Regulator of the KSHV Life Cycle

(2014) Q. Li et al.   JOURNAL OF VIROLOGY

National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis B

(2013) Michael F. Sorrell   ANNALS OF INTERNAL MEDICINE

SIRT2 regulates ciliogenesis and contributes to abnormal centrosome amplification caused by loss of polycystin-1

(2013) Xia Zhou et al.   HUMAN MOLECULAR GENETICS

Sirtuin 1 Regulates Hepatitis B Virus Transcription and Replication by Targeting Transcription Factor AP-1

(2013) J.-H. Ren et al.   JOURNAL OF VIROLOGY

Medical Virology of Hepatitis B: how it began and where we are now

(2013) Wolfram H Gerlich   Virology Journal

Novel directions for diabetes mellitus drug discovery

(2012) Kenneth Maiese et al.   Expert Opinion on Drug Discovery

Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B

(2012) Lorenzo Micco et al.   JOURNAL OF HEPATOLOGY

Sirtuin 1 Is Upregulated in a Subset of Hepatocellular Carcinomas where It Is Essential for Telomere Maintenance and Tumor Cell Growth

(2011) J. Chen et al.   CANCER RESEARCH

Interplay between SIRT proteins and tumour suppressor transcription factors in chemotherapeutic resistance of cancer

(2010) Yolanda Olmos et al.   DRUG RESISTANCE UPDATES

Control of hepatitis B virus at the level of transcription

(2010) M. Quasdorff et al.   JOURNAL OF VIRAL HEPATITIS

Hepatitis B: Reflections on the current approach to antiviral therapy

(2008) Fabien Zoulim et al.   JOURNAL OF HEPATOLOGY

Therapeutic strategies in the management of patients with chronic hepatitis B virus infection

(2007) George V Papatheodoridis et al.   LANCET INFECTIOUS DISEASES